Comments

Oramed Pharmaceuticals

Q: What sector and industry does Oramed Pharmaceuticals (ORMP) operate in?

Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

ORMPNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.30

0.020.88%

At close: -

$2.31

0.010.43%

After Hours: 9:29 AM EDT

Oramed Pharmaceuticals (ORMP) Forecast

News Earnings Oramed Pharmaceuticals (ORMP) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Quotes, Forecast and News Summary

Oramed Pharmaceuticals Stock (NASDAQ: ORMP) stock price, news, charts, stock research, profile.

Open	$2.30
Close	$2.30
Volume / Avg.	131.07K / 147.83K
Day Range	$2.27 - $2.34
52 Wk Range	2.00 - 3.67
Market Cap	$93.12M
P/E Ratio	20.73
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	0.66%
Days to Cover	1.17

Recent News

Top 4 Health Care Stocks That May Crash This Quarter

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Avi Kapoor

Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.

Lisa Levin

Dow Tumbles 250 Points; CarMax Posts Upbeat Results

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. Following the market opening Friday, the Dow traded down 0.74% to 33,695.28 while the NASDAQ fell 0.98% to 13,497.22. The S&P 500, also fell, dropping, 0.78% to 4,347.58.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.30
Close	$2.30
Volume / Avg.	131.07K / 147.83K
Day Range	$2.27 - $2.34
52 Wk Range	2.00 - 3.67
Market Cap	$93.12M
P/E Ratio	20.73
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	0.66%
Days to Cover	1.17

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Oramed Pharmaceuticals (ORMP) stock?

You can purchase shares of Oramed Pharmaceuticals (NASDAQ:ORMP) through any online brokerage.

View our list of the best stock brokerages

Who are Oramed Pharmaceuticals (ORMP) competitors?

Other companies in Oramed Pharmaceuticals’s space includes: Bioage Labs (NASDAQ:BIOA), Telomir Pharmaceuticals (NASDAQ:TELO), Anebulo Pharmaceuticals (NASDAQ:ANEB), NRX Pharmaceuticals (NASDAQ:NRXP) and Milestone Pharmaceuticals (NASDAQ:MIST).

What is the forecast, or price target, for Oramed Pharmaceuticals (ORMP) stock?

Oramed Pharmaceuticals has a consensus price target of $17.33.

What is the current price for Oramed Pharmaceuticals (ORMP)?

The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $2.31 last updated January 21, 2025 at 9:29 AM EST.

Does Oramed Pharmaceuticals (ORMP) pay a dividend?

There are no upcoming dividends for Oramed Pharmaceuticals.

When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?

Oramed Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, March 5, 2025.

Is Oramed Pharmaceuticals (ORMP) going to split?

There is no upcoming split for Oramed Pharmaceuticals.

What sector and industry does Oramed Pharmaceuticals (ORMP) operate in?

Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.